Login
$PRLD
$3.88 +$0.18 (4.86%) Close

Insider Transactions

What Prelude Therapeutics Incorporated's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 4
Sells 0 0
Total trades 0 5

Shares traded

3 months 12 months
Acquired 0 5,630,630
Disposed 0 1,407,000
Net activity +0 +4,223,630

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Ra Capital MANAGEMENT, L.p. 10% owner Apr 27 Other Transaction · J −1,407,000 — — 6,475,882
Orbimed Advisors Llc Director Apr 21 Open-market buy · P +1,126,126 $4.44 +$5M 1,126,126
Orbimed Advisors Llc Director Apr 21 Open-market buy · P +1,689,189 $4.44 +$7.5M 11,808,945
Bonita David P Director Apr 21 Open-market buy · P +1,126,126 $4.44 +$5M 1,126,126
Bonita David P Director Apr 21 Open-market buy · P +1,689,189 $4.44 +$7.5M 11,808,945
Huang Jane President, CMO Oct 04 Withheld — tax / exercise cost · F −3,355 $1.47 −$4.93K 86,917
Huang Jane President, CMO Oct 04 Exercise / conversion · M +9,375 — — 90,272
Huang Jane President, CMO Jul 04 Withheld — tax / exercise cost · F −3,355 $0.79 −$2.66K 80,897
Huang Jane President, CMO Jul 04 Exercise / conversion · M +9,375 — — 84,252
Huang Jane President, CMO Apr 04 Withheld — tax / exercise cost · F −3,355 $0.68 −$2.26K 74,877
Huang Jane President, CMO Apr 04 Exercise / conversion · M +9,375 — — 78,232
Vaddi Krishna CEO Mar 25 Open-market buy · P +675,000 $0.69 +$467K 1,999,296
Combs Andrew Chief Chemistry Officer Mar 25 Open-market buy · P +100,000 $0.69 +$69.3K 480,123
Vaddi Krishna CEO Mar 21 Open-market buy · P +15,000 $0.73 +$11K 1,324,296
Vaddi Krishna CEO Mar 20 Open-market buy · P +5,416 $0.73 +$3.95K 1,309,296
Vaddi Krishna CEO Mar 17 Open-market buy · P +9,106 $0.75 +$6.83K 1,303,880
Vaddi Krishna CEO Mar 14 Open-market buy · P +29,999 $0.75 +$22.6K 1,294,774
Vaddi Krishna CEO Mar 13 Open-market buy · P +50,000 $0.72 +$35.8K 1,264,775
Vaddi Krishna CEO Mar 12 Open-market buy · P +47,500 $0.71 +$33.7K 1,214,775
Huang Jane President, CMO Jan 04 Withheld — tax / exercise cost · F −3,859 $1.39 −$5.36K 68,857

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support